---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-012897"
form_type: "8-K"
ticker: "PEPG"
cik: "0001835597"
company_name: "PepGen Inc."
filed_at: "2022-07-22T23:59:59+00:00"
generated_at: "2026-06-24T09:39:31.752727+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# PepGen Senior VP of Discovery Caroline Godfrey transitions to Scientific Advisory Board effective Aug 1, 2022

## Summary
- Caroline Godfrey steps down as SVP of Discovery; moves to Scientific Advisory Board effective August 1, 2022.
- Transition not due to any disagreement with PepGen's operations, policies, or financials.
- Advisory Board agreement includes annual fee of $64,000, payable quarterly in arrears.
- Godfrey will attend four SAB meetings per year and commit half a day weekly to company activities.

## SEC filing metadata
- accession: 0000950170-22-012897
- form_type: 8-K
- ticker: PEPG
- cik: 0001835597
- company_name: PepGen Inc.
- filed_at: 2022-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835597/000095017022012897/0000950170-22-012897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835597/000095017022012897/pepg-20220722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-012897
- JSON: https://secwatch.observer/filing/0000950170-22-012897.json
- Plain text: https://secwatch.observer/filing/0000950170-22-012897.txt

## Key facts
- Executive change
  Caroline Godfrey changed role as Senior Vice President of Discovery at PepGen Inc..
  - Action: transitioning
  - Role: Senior Vice President of Discovery
  source text: On July 19, 2022, PepGen Inc. (“PepGen”) was notified that Caroline Godfrey would be transitioning from her role as Senior Vice President of Discovery to member of PepGen’s Scientific Advisory Board, effective August 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835597/000095017022012897/0000950170-22-012897-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.